Hakki M - Search Results

1

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Ljungman P, Hakki M, Boeckh M. Ljungman P, et al. Among authors: hakki m. Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011. Hematol Oncol Clin North Am. 2011. PMID: 21236396 Free PMC article.

2

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Ljungman P, Hakki M, Boeckh M. Ljungman P, et al. Among authors: hakki m. Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008. Infect Dis Clin North Am. 2010. PMID: 20466273 Review.

3

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.

Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M. Hakki M, et al. Blood. 2003 Oct 15;102(8):3060-7. doi: 10.1182/blood-2002-11-3472. Epub 2003 Jul 3. Blood. 2003. PMID: 12843000 Free article.

4

American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation.

Hakki M, Aitken SL, Danziger-Isakov L, Michaels MG, Carpenter PA, Chemaly RF, Papanicolaou GA, Boeckh M, Marty FM. Hakki M, et al. Transplant Cell Ther. 2021 Sep;27(9):707-719. doi: 10.1016/j.jtct.2021.05.001. Transplant Cell Ther. 2021. PMID: 34452721 Free article.

5

Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation.

Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Hakki M, et al. Bone Marrow Transplant. 2007 Jun;39(11):687-93. doi: 10.1038/sj.bmt.1705653. Epub 2007 Apr 2. Bone Marrow Transplant. 2007. PMID: 17401395

6

Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.

Perry DA, Hakki M. Perry DA, et al. Among authors: hakki m. Transpl Infect Dis. 2016 Oct;18(5):809-814. doi: 10.1111/tid.12591. Epub 2016 Sep 23. Transpl Infect Dis. 2016. PMID: 27502917

7

Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.

Linder KA, Kovacs C, Mullane KM, Wolfe C, Clark NM, La Hoz RM, Smith J, Kotton CN, Limaye AP, Malinis M, Hakki M, Mishkin A, Gonzalez AA, Prono MD, Ostrander D, Avery R, Kaul DR. Linder KA, et al. Among authors: hakki m. Transpl Infect Dis. 2021 Aug;23(4):e13687. doi: 10.1111/tid.13687. Epub 2021 Jul 20. Transpl Infect Dis. 2021. PMID: 34251742

8

UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.

Gregg K, Hakki M, Kaul DR. Gregg K, et al. Among authors: hakki m. Transpl Infect Dis. 2014 Apr;16(2):320-3. doi: 10.1111/tid.12200. Epub 2014 Mar 13. Transpl Infect Dis. 2014. PMID: 24621186 Free article.

9

Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.

Petersen J, Lindner C, Hakki M. Petersen J, et al. Among authors: hakki m. Biol Blood Marrow Transplant. 2019 Aug;25(8):1648-1653. doi: 10.1016/j.bbmt.2019.04.016. Epub 2019 Apr 16. Biol Blood Marrow Transplant. 2019. PMID: 31002988 Free article.

10

Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Hakki M, Lewis JS 2nd. Hakki M, et al. Infection. 2018 Jun;46(3):431-434. doi: 10.1007/s15010-018-1125-5. Epub 2018 Feb 19. Infection. 2018. PMID: 29460229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page